LungVITamin D and OmegA-3 Trial [ANCILLARY OF 700049031]
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 23 Jan 2019
At a glance
- Drugs Colecalciferol (Primary) ; Omega-3-acid ethyl esters (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms lungVITAL
- 15 Jan 2019 Planned End Date changed from 1 Oct 2017 to 1 Nov 2020.
- 15 Jan 2019 Planned primary completion date changed from 1 Oct 2017 to 1 Nov 2020.
- 07 Mar 2017 The trial design and patient population details published in the Contemporary Clinical Trials